NCT02291198View on ClinicalTrials.gov

Measurement of NK Cell Activity in Whole Blood in Subjects Being Screened for Colorectal Cancer Using Colonoscopy

NACompletedINTERVENTIONAL
Enrollment

1,081

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2017

Conditions
Natural Killer Cell Cytokine Production
Interventions
DEVICE

NK Vue: NK cell activity in stimulated whole blood

One mL of blood is collected from each subject, on the day of colonoscopy, using NK Vue Promoca Tubes blood collection tubes containing a proprietary stimulating cytokine. After incubation, NK cell activity is measured in the collected plasma using an ELISA.

Trial Locations (1)

H1T 2M4

Hopital Maisonneuve-Rosemont, Montreal

All Listed Sponsors
collaborator

Maisonneuve-Rosemont Hospital

OTHER

lead

ATGen Canada Inc

INDUSTRY

NCT02291198 - Measurement of NK Cell Activity in Whole Blood in Subjects Being Screened for Colorectal Cancer Using Colonoscopy | Biotech Hunter | Biotech Hunter